Latest Articles
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - Cureus
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report Cureus
Published: Sept. 25, 2026, 8:57 a.m.
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - cureus.com
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report cureus.com
Published: Sept. 25, 2026, 8:57 a.m.
Women’s health in primary care needs continuity, not visits - KevinMD.com
Women’s health in primary care needs continuity, not visits KevinMD.com
Published: Sept. 15, 2026, 1:43 p.m.
Women’s health in primary care needs continuity, not visits - kevinmd.com
Women’s health in primary care needs continuity, not visits kevinmd.com
Published: Sept. 15, 2026, 1:43 p.m.
NICE backs endometriosis saliva test for use in primary care - Nursing in Practice
NICE backs endometriosis saliva test for use in primary care Nursing in Practice
Published: Sept. 15, 2026, 7:46 a.m.
Colorectal Carcinoma Metastatic to the Breast Mimicking Inflammatory Breast Cancer With Mismatch Repair Status Discordant From a Prior Endometrial Primary: A Case Report and a Review of the Literature - Cureus
Colorectal Carcinoma Metastatic to the Breast Mimicking Inflammatory Breast Cancer With Mismatch Repair Status Discordant From a Prior Endometrial Primary: A Case Report and a Review of the Literature Cureus
Published: Aug. 28, 2026, 11:19 p.m.
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard
Published: Aug. 1, 2026, 6:33 a.m.
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial - Medical Professionals Reference
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial Medical Professionals Reference
Published: July 31, 2026, 4 a.m.
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial - empr.com
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial empr.com
Published: July 31, 2026, 4 a.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks
Published: July 30, 2026, 9:16 p.m.
Link copied to clipboard!